RUNX1 (Runt-related transcription factor 1), a central member of the Runt family, has traditionally been recognized as a master regulator of hematopoietic development and lineage specification, with its dysregulation closely linked to various hematologic malignancies [4,5]. This evidence concerns the gene RUNX1 and hematologic disorder.